Floatz logo

Telbivudine

Chronic Hepatitis B Virus Infection

The Fifth People's Hospital of SuzhouSmall moleculePhase 4 / ApprovedDormant
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Chronic Hepatitis B Virus Infection cohort.

Asset / SponsorPhaseRating
Lamivudine
Yonsei University
Phase 4BBB
Entecavir
Beijing Continent Pharmaceutical Co, Ltd.
Phase 4BBB
Tenofovir Disoproxil Fumarate
Ningbo No.2 Hospital
Phase 4BBB
PEGYINTERFERON-ALFA-2A
Huashan Hospital
Phase 4BB
Tenofovir Alafenamide
Ningbo No.2 Hospital
Phase 4BB

View all 25 →

Same molecule, other indications

Telbivudine is also rated in:

cirrhosis of liverDormant
BBB
Indicative · Phase 4
72 / 100
View asset →
hepatitis B virus infectionDormant
B
Indicative · Phase 3
62 / 100
View asset →
hepatitisDormant
B
Indicative · Phase 3
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →